The latest price target for Alpha Tau Medical (NASDAQ:DRTS) was reported by HC Wainwright & Co. on November 22, 2024. The analyst firm set a price target for $9.00 expecting DRTS to rise to within 12 months (a possible 191.26% upside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for Alpha Tau Medical (NASDAQ:DRTS) was provided by HC Wainwright & Co., and Alpha Tau Medical reiterated their buy rating.

There is no last upgrade for Alpha Tau Medical

There is no last downgrade for Alpha Tau Medical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on November 22, 2024 so you should expect the next rating to be made available sometime around November 22, 2025.

While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a reiterated with a price target of $9.00 to $9.00. The current price Alpha Tau Medical (DRTS) is trading at is $3.09, which is out of the analyst’s predicted range.